What Is ISO 8362-1?
ISO 8362-1:2018 (Injection containers and accessories — Part 1: Injection vials made of borosilicate glass) is the international standard that specifies the form, dimensions, material, performance, and packaging requirements for glass vials intended for parenteral (injectable) preparations.
For 503A and 503B compounding pharmacies, sourcing vials that comply with ISO 8362-1 is not optional — it is a fundamental requirement for ensuring patient safety and regulatory compliance.
Scope of the Standard
ISO 8362-1 covers:
- Glass type classification (Type I borosilicate)
- Dimensional requirements (external diameter, height, neck finish)
- Capacity designations (nominal and brimful volumes)
- Glass quality requirements (hydrolytic resistance, chemical durability)
- Visual defects (bubbles, inclusions, surface imperfections)
- Mechanical strength (thermal shock resistance, internal pressure)
Key Requirements Explained
Glass Type I Borosilicate
ISO 8362-1 mandates Type I borosilicate glass, which offers:
- High hydrolytic resistance (< 1.0 ml 0.01M HCl per gram of glass grains)
- Low alkali release preventing pH shifts in drug solutions
- Excellent thermal shock resistance (withstands ΔT > 120°C)
- Chemical inertness compatible with most pharmaceutical formulations
The borosilicate composition typically contains:
- SiO₂: 70–80%
- B₂O₃: 7–13%
- Na₂O + K₂O: 4–8%
- Al₂O₃: 2–7%
Dimensional Specifications
Each vial size designation (e.g., 2R, 6R, 10R, 20R, 50R) has precise dimensional requirements:
| Designation | Nominal Capacity | External Diameter | Overall Height |
|---|---|---|---|
| 2R | 2 ml | 16.0 ± 0.20 mm | 35.0 ± 0.50 mm |
| 6R | 6 ml | 22.0 ± 0.20 mm | 40.0 ± 0.50 mm |
| 10R | 10 ml | 24.0 ± 0.20 mm | 45.0 ± 0.50 mm |
| 20R | 20 ml | 30.0 ± 0.20 mm | 55.0 ± 0.50 mm |
| 50R | 50 ml | 43.5 ± 0.30 mm | 73.0 ± 0.75 mm |
These tight tolerances ensure:
- Proper stopper seating and seal integrity
- Compatibility with automated filling equipment
- Consistent labeling and packaging
Neck Finish (Crimp Seal Type)
The standard specifies two primary neck finishes:
- 13mm crimp for vials ≤ 5ml
- 20mm crimp for vials > 5ml
The neck finish dimensions are critical for:
- Stopper compression and seal integrity
- Aluminum seal crimping force
- Container-closure integrity testing (CCIT) results
Hydrolytic Resistance Testing
ISO 8362-1 references ISO 720 (surface test) and ISO 719 (grain test) for verifying glass quality:
Surface Test (ISO 720):
- Fill vials with purified water
- Autoclave at 121°C for 60 minutes
- Titrate extracted alkali
- Type I glass: ≤ 1.0 ml 0.01M HCl per 100 ml
Grain Test (ISO 719):
- Crush glass to specified particle size
- Boil in purified water for 30 minutes
- Titrate extracted alkali
- Type I glass: ≤ 1.0 ml 0.01M HCl per gram
Why ISO 8362-1 Compliance Matters
1. Patient Safety
Non-compliant vials may:
- Release alkali that destabilizes drug formulations
- Have dimensional defects causing stopper leakage
- Contain glass particles from delamination
- Fail under sterilization conditions
2. Regulatory Requirements
- FDA requires container-closure systems to be "suitable for intended use"
- USP <660> (Containers — Glass) references ISO standards
- cGMP requires documented evidence of component quality
- State boards of pharmacy may audit packaging documentation
3. Operational Reliability
- Consistent dimensions ensure automated filling accuracy
- Proper neck finish prevents seal failures
- Thermal shock resistance supports autoclaving
- Low particulate counts reduce rejection rates
How to Verify Supplier Compliance
When evaluating a vial supplier, request:
-
Certificate of Analysis (COA) for each lot showing:
- Dimensional measurements
- Hydrolytic resistance results
- Visual inspection results
- Particulate counts (for RTU vials)
-
ISO 8362-1 declaration of conformity from the manufacturer
-
TSE/BSE certificate confirming no animal-derived materials
-
Drug Master File (DMF) reference number (if applicable)
-
Stability data demonstrating compatibility with your specific formulations
Common Non-Compliance Issues
Watch for these red flags:
- Suppliers who cannot provide ISO 8362-1 COAs
- Vials with visible cosmetic defects (bubbles > 1mm, scratches)
- Dimensional variations exceeding standard tolerances
- Glass delamination (flaking) after sterilization
- Inconsistent neck finish causing seal failures
Conclusion
ISO 8362-1 compliance is the foundation of safe pharmaceutical packaging. Every vial that enters your cleanroom should have documented evidence of conformity to this standard. Working with a supplier who understands these requirements — and can provide complete documentation — protects your patients, your license, and your business.
All Core Distro glass vials are manufactured to ISO 8362-1:2018 standards with full COA documentation, TSE/BSE certificates, and dimensional verification reports included with every shipment. Request documentation samples.

